Myriad Genetics
MYGN
MYGN
223 hedge funds and large institutions have $1.7B invested in Myriad Genetics in 2016 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 91 increasing their positions, 72 reducing their positions, and 57 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less call options, than puts
Call options by funds: $ | Put options by funds: $
44% less first-time investments, than exits
New positions opened: 32 | Existing positions closed: 57
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
223
Holding in Top 10
–
Calls
$5.41M
Puts
$7.99M
Top Buyers
| 1 | +$48.1M | |
| 2 | +$32.9M | |
| 3 | +$25.5M | |
| 4 |
Neuberger Berman Group
New York
|
+$24.2M |
| 5 |
NTC
North Tide Capital
Boston,
Massachusetts
|
+$20.6M |
Top Sellers
| 1 | -$98.4M | |
| 2 | -$62.9M | |
| 3 | -$20.5M | |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$17.9M |
| 5 |
RA
Royce & Associates
New York
|
-$17.4M |